Purpose: The tumor microenvironment is known to be associated with the metabolic activity of cancer cells and local immune reactions. We hypothesized that glucose metabolism measured by 2-deoxy-2-( F-FDG PET-CT prior to gastrectomy. In resected tumor specimens, TIL subsets, including cluster of differentiation (CD) 3, CD4, CD8, Forkhead box P3 (Foxp3), and granzyme B, were subjected to immunohistochemical analysis. The prognostic nutritional index (PNI) was calculated as: (10×serum albumin value)+(0.005×peripheral lymphocyte counts). Additionally, the maximum standard uptake value (SUV max ) was calculated to evaluate the metabolic activity of cancer cells. Results: The SUV max was positively correlated with larger tumor size (R=0.293; P=0.029) and negatively correlated with PNI (R=−0.407; P=0.002). A higher SUV max showed a marginal association with higher CD3 (+) T lymphocyte counts (R=0.227; P=0.092) and a significant association with higher Foxp3 (+) T lymphocyte counts (R=0.431; P=0.009). No other clinicopathological characteristics were associated with SUV max or TILs. Survival analysis, however, indicated that neither SUV max nor Foxp3 held prognostic significance. Conclusions: FDG uptake on PET-CT could be associated with TILs, especially regulatory T cells, in gastric cancer. This finding may suggest that PET-CT could be of use as a noninvasive tool for monitoring the tumor microenvironment in patients with gastric cancer.
INTRODUCTION
Gastric cancer is the fourth most common cancer worldwide, and the third leading cause of cancer-related death [1] . Despite improvements in diagnostic methods and therapeutic strategies, the prognosis of gastric cancer is still determined by cancer stage alone [2] . However, accurate tumor staging can only be achieved after surgical resection. 
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To predict prognosis in patients with cancer, 2-deoxy-2-( 
FDG PET-CT) has been widely used [3] [4] [5] . In PET-CT analysis, increased cell metabolic activity is reflected by increased FDG uptake. This mechanism of action allows PET-CT to be used in diagnosing cancer severity [3, 6] and in predicting response to preoperative chemotherapy [7] . In this respect, the metabolic activity of cancers can be considered an important factor affecting tumor biology and patient prognosis. In gastric cancer, however, the sensitivity and specificity of 18 F-FDG PET-CT have been found to vary according to histologic type [8] , limiting the role of this modality in the detection of primary tumors [9] . Notwithstanding, several studies have reported that increased FDG uptake by primary tumors and metastatic lymph nodes is associated with poor prognosis in gastric cancer [10] [11] [12] .
Recently, the tumor microenvironment has emerged as another aspect important in the further understanding of tumor biology [13] . In particular, the tumor microenvironment has been found to play an essential role in the metabolic activity of cancers [14] . In this respect, the potential utility of 18 F-FDG PET-CT as an indirect tool for monitoring the tumor microenvironment has been suggested [14] [15] [16] [17] . Additional factors associated with the tumor microenvironment are tumor infiltrating lymphocytes (TILs) [18] [19] [20] . TILs are considered prognostic factors in local anti-tumor immunity and oncologic outcomes [21] [22] [23] [24] . Indeed, in gastric cancer, several studies have reported a relationship between subsets of TILs and oncologic outcomes [22, 25, 26] . Interestingly, regulation of TIL subsets and the function of T cells have been shown to be influenced by the tumor microenvironment [18, 19, 27, 28] .
We hypothesized that the tumor microenvironment would be associated with the metabolic activity of cancer cells and would contribute to local immune responses in gastric cancer. Accordingly, we explored associations between FDG uptake on PET-CT and TILs in patients with gastric cancer.
MATERIALS AND METHODS

Patients
The present study included 56 patients with gastric cancer who underwent surgical resection and 18 F-FDG PET-CT for staging workup at Severance Hospital, Yonsei University College of Medicine between June 2005 and December 2010. The medical records of these patients were retrospectively reviewed, and clinicopathological data were collected, including age, sex, tumor size, histologic type, pathologic T classification, and N classification. Tumor staging and pathologic grading were based on the American Joint Committee on Cancer (AJCC), seventh edition [29] . We obtained PET-CT workup and laboratory data, including serum albumin levels and lymphocyte counts, from baseline workup conducted within 2 months prior to surgery. The prognostic nutritional index (PNI) was calculated as follows [30] :
This study was approved by the Institutional Review Board of Severance Hospital, Yonsei University Health System (4-2017-0824). 18 F-FDG PET-CT scans were performed with a PET-CT scanner (Discovery STe; GE Healthcare, Little Chalfont, UK; or Biograph TruePoint 40; Siemens Healthcare, Erlangen, Germany). All patients fasted for at least 6 hours before undergoing PET-CT scan, and a dose of 5.5 MBq/ kg of 18 F-FDG was intravenously injected 60 minutes prior to PET-CT. CT scans were initially performed at 30 mA and 130 kVp without contrast enhancement. After the CT scan was complete, a PET scan was performed with an acquisition time of 3 minutes per bed position in 3-dimensional mode. PET images were reconstructed using ordered subset expectation maximization with an attenuation correction. 18 F-FDG PET-CT images were reviewed by nuclear medicine physicians (Fig. 1A) . The maximum standard uptake value (SUV max ) on PET images was measured using volume viewer software (MIM-6.4; MIM software Inc., Cleveland, OH, USA). Each tumor was examined with a spherical-shaped volume of interest (VOI) that included the entire lesion in the axial, sagittal, and coronal planes. Using CT images, 18 F-FDG uptake of normal organs, such as the brain, heart, liver, kidney, and small bowel was not included in the VOI. The SUV max of the VOI was calculated as: SUV max of the VOI=(decay corrected activity/tissue volume)/(injected dose/body weight)
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F-FDG PET-CT imaging
Immunohistochemistry of TILs
Immunohistochemical staining was performed on formalin-fixed, paraffin-embedded gastric cancer tissue sections. We used primary monoclonal antibodies for TIL subsets, including cluster of differentiation (CD) 3 (T lymphocytes, 1:100; Lab Vision Corp., Fremont, CA, USA; Cambridge, UK; Fig. 1E ), and granzyme B (activated cytotoxic T lymphocytes, 1:100; Lab Vision Corp.; Fig. 1F ). Stained slides were reviewed by an experienced pathologist who was blinded to patient data. Precise immunohistochemical staining methods and quantification of TILs were described in our previous study [22] .
Statistical analysis
Categorical data are expressed as numbers with percentages, and continuous variables are expressed as means±standard deviations. Continuous variables were analyzed with analysis of variance (ANOVA). Correlation analyses were performed with Spearman's correlation analysis test. P-values less than 0.05 were considered statistically significant. Overall survival (OS) was compared with Kaplan-Meier analysis and the log-rank test. All statistical analyses were performed with SPSS software, version 23 (IBM Corporation, Chicago, IL, USA).
RESULTS
Patients
Clinicopathologic characteristics of the patients are shown in Table 1 
SUV max on PET-CT and associated characteristics
In correlation analysis of clinicopathological characteristics, SUV max was not associated with age, sex, histologic subtype, N classification, or final stage. A high SUV max value was associated with larger tumor size ( Fig. 2A, R=0 .293; P=0.029) and advanced T classification (Fig. 2B, P=0 .039), and showed a negative correlation with PNI (Fig. 2C , R=−0.407; P=0.002). In correlation analysis of TILs (Fig. 2D-H) , SUV max showed a marginal association with CD3 (+) lymphocytes (Fig. 2D,  R=0 .227; P<0.092) and a significant association with Foxp3 (+) regulatory T cell counts (Fig. 2G,  R=0 .431; P<0.001). CD4, CD8, and granzyme B were not associated with SUV max .
Foxp3 (+)TILs and associated characteristics
Because only Foxp3 was correlated with SUV max , we performed further investigation of Foxp3 and clinicopathological characteristics. Although Foxp3 and SUV max were significantly correlated, Foxp3 counts showed poor correlation with clinicopathological characteristics, as shown in Fig. 3 . Notably, however, Foxp3 counts were highest in patients with T3 disease and lowest in those with T4 disease (Fig. 3C , mean Foxp3 count=23.27 and 14.65, respectively, P=0.033).
Survival analysis
No OS differences were found between the groups with high and low SUV max (Fig. 4A) or between the high and low Foxp3 (+) T cell groups (Fig. 4B) .
DISCUSSION
In this study, we used SUV max on 18 F-FDG PET-CT to evaluate the metabolic activity of gastric cancer tumors and TIL subsets as a reflection of local immune responses. SUV max showed positive correlations with tumor size and regulatory T lymphocytes, and a negative correlation with PNI. We noted no prognostic significance for SUV max and regulatory T lymphocytes in the present study.
Standard uptake value is the ratio between 18 F-FDG concentrations in a tumor and those throughout the entire body, and SUV max is the maximum concentration of 18 F-FDG in an organ of interest. High SUV max generally indicates increased cancer metabolism, and has been shown to be associated with aggressive behavior, advanced disease status, and poor oncologic outcomes [5, 11, 31, 32] . In the present study, we identified associations among tumor size, SUV max , and regulatory T lymphocytes. The observed association between large tumor size and high SUV max corroborates the findings of a previous report on gastric cancer [16] . To the best of our knowledge, however, we are the first to report a strong association between SUV max and TILs: this relationship had never previously been explored in gastric cancer, and has rarely been studied in other solid cancers [33] .
Hypothetically, increased glucose uptake in cancerous tissue would likely be associated with changes in the tumor microenvironment, reflecting tumor proliferation and increased 388 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e43
FDG Uptake in PET-CT and TILs 21.9±16.6 Data are shown as mean±standard deviation or number (%). AWD = well-differentiated; AMD = moderately differentiated; APD = poorly differentiated; TNM = tumor, node, and metastasis; PNI = prognostic nutritional index; SUV max = maximum standard uptake value; TIL = tumor infiltrating lymphocyte; CD = cluster of differentiation; Foxp3 = Forkhead box P3. *Mucinous-1, signet-ring cell cancer-1, and undifferentiated-7.
glucose metabolism [34, 35] . These changes are also known to influence regulation of TIL subsets and the function of T cells [18, 19, 27, 28] . Among the many factors in the tumor microenvironment that modulate the differentiation and function of TILs [36] [37] [38] [39] , the most relevant connection between SUV max and Foxp3 could be hypoxia and acidic conditions. Regarding the former, FDG uptake is upregulated in hypoxic conditions [17, 40, 41] , and it is well-known that hypoxia modulates immune responses in the tumor microenvironment [36, 42] and promotes proliferation of regulatory T cells [18, 43] . In relation to the latter, high lactate concentrations in the tumor microenvironment have been found to block lactate export in T cells, thereby perturbing the metabolism and function of these cells [27] . Although our study did not explore the mechanism linking high FDG uptake and high The median OS in the low Foxp3 group was 89 months, while the median OS in the high Foxp3 group was undefined (P=0.767). The differences between the groups were calculated using the log-rank test. SUV max = maximum standard uptake value; Foxp3 = Forkhead box P3; OS = overall survival.
